Impact of COVID-19 in public health: Prevalence and preventive approaches

Pak J Pharm Sci. 2020 Jul;33(4):1739-1745.

Abstract

The outbreak of CoVID-19 infection rapidly increases worldwide. Most of the continents affecting from CoVID-19 and still widening its burden disease (Jones DS, 2020; Lai et al., 2020). Along with its fatality rates, CoVID-19 has caused physiological disturbances in the society and termed as "coronophobia". CoVID-19 with renal failure, severe pneumonia and respiratory syndrome patients have been reported to increase the severity of disease conditions (Sevim et al., 2020). Also, CoVID-19 with cancer patients increase the higher risk of infections. Currently, there is no vaccine or specific treatment against CoVID-19 and drug research centres continuously investigating the potential drug against CoVID-19 (Osama and Amer, 2020). For the past 20 years two major coronavirus epidemics have occurred in public includes SARS-CoV approximately 8000 cases and 800 deaths and MERS-CoV 2,500 cases and 800 deaths and these continuing sporadically (Cascella et al., 2020).

MeSH terms

  • Age Factors
  • COVID-19 / epidemiology*
  • COVID-19 / mortality
  • COVID-19 / prevention & control
  • COVID-19 / transmission
  • Communicable Disease Control*
  • Comorbidity
  • Humans
  • Infectious Disease Incubation Period
  • Prevalence
  • Public Health
  • SARS-CoV-2
  • Sex Factors